MedPath

Outcomes in Lower Extremity Soft Tissue Sarcoma Patients After Limb Salvage

Completed
Conditions
Limb Salvage
Registration Number
NCT02536053
Lead Sponsor
Helsinki University Central Hospital
Brief Summary

This study aims to:

1. validate the Finnish version of the Musculoskeletal Tumor Society scale and the Toronto Extremity Salvage Score lower extremity sections and to

2. assess the functional ability and health-related quality of life (HRQoL) of lower extremity sarcoma patients who have undergone limb salvage surgery.

Detailed Description

The first purpose of this study is to validate the Finnish version of the Musculoskeletal Tumor Society scale and the Toronto Extremity Salvage Score upper extremity sections. The second purpose is to chart the functional capabilities and health-related quality of life (HRQoL) of upper extremity sarcoma patients who have undergone limb salvage surgery with local or free flaps.

Patient hospital records are retrospectively reviewed to chart the demographic and clinical data.

The recruitment of patient takes place at the outpatient clinic of Department of Oncology, Helsinki University Hospital. The study includes a cross-sectional assessment at one year follow-up with five validated questionnaires. A follow-up is conducted three years after surgery in the outpatient clinic.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
141
Inclusion Criteria
  • Lower extremity soft tissue sarcoma locating in between hip/gluteus to foot
  • No metastasis at the time of diagnosis
  • Undergone limb salvage surgery
  • A minimum of 1 year follow-up
  • Written consent
  • Age > 18
Exclusion Criteria
  • Age <18
  • No limb-salvage surgery due to sarcoma

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Validity of the lower-limb Musculoskeletal Tumor Society score and the Toronto Extremity Salvage Scoretwo to five years

The validity is studied

Reliability of the lower-limb Musculoskeletal Tumor Society score and the Toronto Extremity Salvage Scoretwo to five years

The test-retest reliability is studied

Health-related quality of life after limb salvagetwo to five years

Assessment of health-related quality of life

Assessment of the functional ability after limb salvagetwo to five years

Assessment of functional ability

Secondary Outcome Measures
NameTimeMethod
Quality of Life Questionnaire-Core 30two to five years

Health-related quality of life assessment

The 15-dimensions health-related quality of life instrumenttwo to five years

Health-related quality of life assessment

The Musculoskeletal Tumor Society score lower extremity sectiontwo to five years

Functional assessment of the reconstructed limb

The Toronto Extremity Salvage Score lower extremity sectiontwo to five years

Functional assessment of the reconstructed limb

Trial Locations

Locations (1)

Cancer center, Helsinki University Hospital and University of Helsinki

🇫🇮

Helsinki, Helsinki And Uusimaa, Finland

© Copyright 2025. All Rights Reserved by MedPath